STAND. COM. REP. NO. 3281

Honolulu, Hawaii

RE: S.C.R. No. 116

 

 

Honorable Robert Bunda

President of the Senate

Twenty-Third State Legislature

Regular Session of 2006

State of Hawaii

Sir:

Your Committee on Health, to which was referred S.C.R. No. 116 entitled:

"SENATE CONCURRENT RESOLUTION SUPPORTING THE UNITED STATES FOOD AND DRUG ADMINISTRATION'S NATIONAL CAMPAIGN TO RAISE AWARENESS AND INFORM WOMEN ABOUT MENOPAUSAL HORMONE THERAPY AND DESIGNATING SEPTEMBER AS MENOPAUSE AWARENESS MONTH IN HAWAII,"

begs leave to report as follows:

The purpose of this measure is to support the Food and Drug Administration's national campaign to raise awareness and inform women about menopausal hormone therapy and to designate September as Menopause Awareness Month in Hawaii.

Your Committee received testimony in support of this measure from the American Menopause Foundation, Inc. and Wyeth Pharmaceuticals.

Your Committee finds that in 2005 more than fifty million American women were affected by menopause. By educating and raising awareness of the health risks and symptoms, and hormone therapies available to treat menopause, women in Hawaii will be able to enhance and prolong their lives.

As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee concurs with the intent and purpose of S.C.R. No. 116 and recommends its adoption.

Respectfully submitted on behalf of the members of the Committee on Health,

____________________________

ROSALYN H. BAKER, Chair